Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 26/5/2020
SIETES contiene 93011 citas

 1 a 20 de 28 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Robertson K, Marshman LAG, Plummer D, Downs E. Effect of gabapentin vs pregabalin on pain intensity in adults ith chronic sciatica: a randomized clinical trial. JAMA Neurology 2018:15 de octubre. [Ref.ID 102863]
2. Cita con resumen
Read J, Cartwright C, Gibson K. Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants. Psychiatry Research 2014;216:67-73. [Ref.ID 97503]
3. Cita con resumen
Anónimo. Two new drugs for weight loss. Med Lett Drugs Ther 2012;43:69-71. [Ref.ID 93703]
4. Cita con resumen
Zaccara G, Perucca P, Gangemi PF. The adverse event profile of pregabalin across different disorders: a meta-analysis. Eur J Clin Pharmacol 2012;68:903-12. [Ref.ID 93103]
5. Cita con resumen
Pérez-Llobet S, Rey MV, Fabre N, Ory F, Spampinato U, Montastruc J-L, Rascol O. Do Parkinson's disease patients disclose their adverse events spontaneously?. Eur J Clin Pharmacol 2012;68:857-65. [Ref.ID 92830]
7. Cita con resumen
Vitalone A, Menniti-Ippolito F, Moro PA, Firenzuoli F, Raschetti R, Mazzanti G. Suspected adverse reactions associated with herbal products used for weight loss: a case series reported to the Italian National Institute of Health. Eur J Clin Pharmacol 2011;67:215-24. [Ref.ID 90094]
8. Cita con resumen
Winstock AR, Ford C, Witton J. Assessment and management of cannabis use disorders in primary care. BMJ 2010;340:800-4. [Ref.ID 88314]
9. Cita con resumen
Anónimo. Trastorns dentals induïts per fàrmacs. Butlletí de Farmacovigilància de Catalunya 2009;7:1-3. [Ref.ID 85602]
11.Tiene citas relacionadas
Doody R, Seely L, Thomas R, Sano M, Aisen P. Statistical treatment of withdrawal in trials of anti-dementia drugs. Authors' reply. Lancet 2008;372:1383. [Ref.ID 84205]
12.Tiene citas relacionadas
Mackinnon A. Statistical treatment of withdrawal in trials of anti-dementia drugs. Lancet 2008;372:1382-3. [Ref.ID 84204]
13.Tiene citas relacionadas Cita con resumen
Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D, on behalf of the dimebon investigators. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study. Lancet 2008;372:207-15. [Ref.ID 83623]
14.Tiene citas relacionadas
Burns A, Jacoby R. Dimebon in Alzheimer's disease: old drug for new indication. Lancet 2008;372:179-80. [Ref.ID 83617]
15. Cita con resumen
Nelson HD. Menopause. Lancet 2008;371:760-70. [Ref.ID 82270]
Brito-Zerón P, Ramos-Casals M, Nardi N, Font J. Resultados del tratamiento con pilocarpina oral en 100 pacientes con síndrome de Sjögren primario. Med Clin (Barc) 2006;126:637. [Ref.ID 76979]
18.Tiene citas relacionadas Cita con resumen
Leucht S, Wahlbeck K, Engel R, Hamann J, Kissling W. New generation versus conventional antipsychotics. Authors' reply. Lancet 2003;362:404. [Ref.ID 67060]
20. Cita con resumen
Weber W. Anticholinergic side effects mimic diseases of old age. Lancet 2000;356:833. [Ref.ID 52572]
Seleccionar todas
 1 a 20 de 28 siguiente >>